Biomerica (BMRA) Liabilities and Shareholders Equity (2011 - 2026)

Biomerica's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 33.87% year-over-year to $4.9 million; the TTM figure through Feb 2026 stood at $23.7 million (down 25.38% YoY), while the FY2025 annual figure was $5.9 million, down 35.76% from the prior year.
• Liabilities and Shareholders Equity came in at $4.9 million for Q1 2026 at Biomerica, down from $6.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $17.6 million in Q1 2022 to a low of $4.9 million in Q1 2026.
• A 5-year average of $9.6 million and a median of $9.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity soared 31.56% in 2022 and slumped 53.25% in 2023, its largest moves.
• Biomerica's Liabilities and Shareholders Equity stood at $9.9 million in 2022, then increased by 19.41% to $11.8 million in 2023, then sank by 38.52% to $7.3 million in 2024, then declined by 17.05% to $6.0 million in 2025, then dropped by 19.16% to $4.9 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $4.9 million, $6.0 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison